Global Research and Discovery Group and Impact Biomedical's Laetose Technology Granted U.S. Patent Allowance [Yahoo! Finance]
DSS, Inc. (DSS)
NASDAQ:AMEX Investor Relations:
dsssecure.com
Company Research
Source: Yahoo! Finance
technology in collaboration Impact Biomedical Inc., a biotechnology holding company which is a wholly owned subsidiary of DSS, Inc. continues to make waves with its diverse range of impactful projects. Today, the spotlight shines on the success of GRDG's Laetose technology, recently granted a (UIS) Patent Allowance by the United States Patent and Trademark Office (USPTO) for its exceptional ability to inhibit tumor necrosis factor alpha (TNF-a). Founded in 2014, GRDG has consistently spearheaded scientific exploration and innovation. Daryl Thompson and GRDG have been able to create this new sugar Laetose and are now in coordination with its contacts of global food conglomerates for out-licensing opportunities. The recent grant of a UIS Patent Allowance by the USPTO for Laetose solidifies GRDG's position as a trailblazer in scientific innovation. Laetose's ability to inhibit TNF-a, a cytokine linked to inflammation and various chronic conditions, opens new avenues for research and
Show less
Read more
Impact Snapshot
Event Time:
DSS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DSS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DSS alerts
High impacting DSS, Inc. news events
Weekly update
A roundup of the hottest topics
DSS
Sec Filings
- 3/27/24 - Form 10-K
- 2/9/24 - Form 8-K
- DSS's page on the SEC website